Pain and quality of life in patients undergoing radiotherapy for spinal metastatic disease treatment

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorValesin Filho, Edgar S.
dc.creatorDe Abreu, Luiz Carlos
dc.creatorLima, Guilherme H.V.
dc.creatorDe Cubero, Daniel I.G.
dc.creatorUeno, Fabrício H.
dc.creatorFigueiredo, Gustavo S.L.
dc.creatorValenti, Vitor E.
dc.creatorDe Mello Monteiro, Carlos Bandeira
dc.creatorWajnsztejn, Rubens
dc.creatorFujiki, Edison N.
dc.creatorNeto, Modesto Rolim
dc.creatorRodrigues, Luciano M.
dc.date2014-05-27T11:28:31Z
dc.date2016-10-25T18:44:45Z
dc.date2014-05-27T11:28:31Z
dc.date2016-10-25T18:44:45Z
dc.date2013-02-20
dc.date.accessioned2017-04-06T02:14:23Z
dc.date.available2017-04-06T02:14:23Z
dc.identifierInternational Archives of Medicine, v. 6, n. 1, 2013.
dc.identifier1755-7682
dc.identifierhttp://hdl.handle.net/11449/74617
dc.identifierhttp://acervodigital.unesp.br/handle/11449/74617
dc.identifier10.1186/1755-7682-6-6
dc.identifier2-s2.0-84873939943.pdf
dc.identifier2-s2.0-84873939943
dc.identifierhttp://dx.doi.org/10.1186/1755-7682-6-6
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/895378
dc.descriptionBackground: Radiotherapy is an important tool in the control of pain in patients with spinal metastatic disease. We aimed to evaluate pain and of quality of life of patients with spinal metastatic disease undergoing radiotherapy with supportive treatment. Methods. The study enrolled 30 patients. From January 2008 to January 2010, patients selection included those treated with a 20Gy tumour dose in five fractions. Patients completed the visual analogue scale for pain assessment and the SF-36 questionnaire for quality of life assessment. Results: The most frequent primary sites were breast, multiple myeloma, prostate and lymphoma. It was found that 14 spinal metastatic disease patients (46.66%) had restricted involvement of three or fewer vertebrae, while 16 patients (53.33%) had cases involving more than three vertebrae. The data from the visual analogue scale evaluation of pain showed that the average initial score was 5.7 points, the value 30days after the end of radiotherapy was 4.60 points and the average value 6months after treatment was 4.25 points. Notably, this final value was 25.43% lower than the value from the initial analysis. With regard to the quality of life evaluation, only the values for the functional capability and social aspects categories of the questionnaire showed significant improvement. Conclusion: Radiotherapy with supportive treatment appears to be an important tool for the treatment of pain in patients with spinal metastatic disease. © 2013 Valesin Filho et al; licensee BioMed Central Ltd.
dc.languageeng
dc.relationInternational Archives of Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNeoplasm metastasis
dc.subjectQuality of life
dc.subjectRadiotherapy
dc.subjectdexamethasone
dc.subjectadult
dc.subjectaged
dc.subjectbreast cancer
dc.subjectcancer pain
dc.subjectcancer radiotherapy
dc.subjectclinical article
dc.subjectfemale
dc.subjecthuman
dc.subjectlymphoma
dc.subjectmale
dc.subjectmultiple myeloma
dc.subjectprostate cancer
dc.subjectquality of life
dc.subjectradiation dose
dc.subjectShort Form 36
dc.subjectsocial aspect
dc.subjectspinal metastatic disease
dc.subjectspine metastasis
dc.subjectvisual analog scale
dc.titlePain and quality of life in patients undergoing radiotherapy for spinal metastatic disease treatment
dc.typeOtro


Este ítem pertenece a la siguiente institución